HL60 Antigen Activators
The HL60 antigen represents a protein marker often associated with cellular processes within the HL-60 cell line, a type of human leukemia cell predominantly used in research settings to study hematopoiesis and the immune response. The intricate processes governing the expression of proteins like the HL60 antigen are subject to a complex network of regulatory mechanisms, including epigenetic modifications, transcription factor binding, and signal transduction pathways. Understanding these pathways can reveal valuable insights into how cellular differentiation and proliferation might be guided or altered under specific conditions. The HL60 cell line, with its capacity to differentiate into various blood cell types when exposed to certain compounds, provides a robust system for exploring these regulatory mechanisms.
Research has identified a diverse array of chemicals that can potentially stimulate the expression of the HL60 antigen, each operating through unique biochemical pathways. Compounds such as all-trans retinoic acid (ATRA) and its analogue, tretinoin, are known to play a significant role in modulating gene expression by interacting with nuclear receptors, thus altering the transcriptional landscape in favor of differentiation-related genes. Other compounds like dibutyryl-cAMP (db-cAMP) may elevate the expression of the HL60 antigen through the activation of cAMP-dependent protein kinase A, which in turn phosphorylates key proteins involved in the regulation of gene expression. Additionally, agents such as phorbol 12-myristate 13-acetate (PMA) are recognized for their ability to activate protein kinase C, initiating a cascade of intracellular signaling that can culminate in varied gene expression profiles, including the upregulation of differentiation markers. These activators, among others, are central to expanding our understanding of the molecular underpinnings that govern protein expression in leukemic cells and the potential modulation of these pathways in a controlled research environment.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could upregulate HL60 antigen by differentiating HL-60 cells into granulocytes, which involves the activation of retinoic acid receptors leading to transcriptional changes. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol might stimulate HL60 antigen by binding to the vitamin D receptor, enhancing the transcription of genes associated with cell maturation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA has the potential to increase HL60 antigen levels through the direct activation of protein kinase C, resulting in a cascade of intracellular events that culminate in cellular differentiation. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Arsenic Trioxide may upregulate HL60 antigen by promoting partial differentiation and apoptosis in leukemic cells, through oxidative stress and mitochondrial dysfunction. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP could stimulate the expression of HL60 antigen via elevation of intracellular cAMP levels, which can lead to the activation of protein kinase A (PKA) and the subsequent phosphorylation of transcription factors. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate might enhance the transcription of genes encoding HL60 antigen by inhibiting histone deacetylases, leading to a relaxed chromatin structure and increased gene accessibility. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By incorporating into DNA and RNA, 5-Azacytidine could induce HL60 antigen expression due to the inhibition of methyltransferases, thereby reversing epigenetic silencing of genes. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide may lead to an increase in HL60 antigen transcription by causing DNA strand breaks and activating the DNA damage response, which can include the upregulation of certain cell cycle regulators. | ||||||
Amphotericin B | 1397-89-3 | sc-202462 sc-202462A sc-202462B | 100 mg 500 mg 1 g | $70.00 $142.00 $223.00 | 10 | |
Amphotericin B could incidentally stimulate HL60 antigen production by creating pores in the cell membrane, which might lead to an influx of calcium ions and activation of calcium-dependent signaling pathways. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram might promote the accumulation of HL60 antigen by inhibiting the proteasome's degradation function, leading to increased levels of various proteins including differentiation markers. | ||||||